I-Favipiravir CAS 259793-96-9 T-705 Purity ≥99.0% (HPLC) COVID-19 API Factory High Quality

Incazelo emfushane:

Igama Lekhemikhali: Favipiravir;T-705

I-CAS: 259793-96-9

Ukubukeka: Impushana Emhlophe ukuya Emhlophe

Ubumsulwa: ≥99.0% (HPLC)

Ekwelapheni i-Influenza Virus Infections kanye ne-COVID-19

Ikhwalithi ephezulu ye-API, Ukukhiqiza Kwezentengiso

Inquiry: alvin@ruifuchem.com

Thumela i-imeyili kithi

Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

Umkhiqizi onokuhlanzeka Okuphezulu kanye Nekhwalithi Ezinzile
I-Favipiravir yezohwebo kanye Nezixhumanisi Ezihlobene:
I-Favipiravir CAS 259793-96-9
I-2-Aminopropanediamide CAS 62009-47-6
I-Diethyl Aminomalonate Hydrochloride CAS 13433-00-6
I-3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3
I-6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8
I-6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9
3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8

Chemical Properties:

Igama Lekhemikhali	I-Favipiravir
Omqondofana	I-T-705;I-6-Fluoro-3-Hydroxy-2-Pyrazinecarboxamide
Inombolo ye-CAS	259793-96-9
Inombolo yeCAT	I-RF-API18
Isimo Sesitoko	Esitokweni, Isikali Sokukhiqiza Sifika Emakhulwini Amakhilogremu
I-Molecular Formula	I-C5H4FN3O2
Isisindo samangqamuzana	157.1
Ibhrendi	I-Ruifu Chemical

Imininingwane:

Into	Imininingwane
Ukubukeka	Impushana Emhlophe Kuya Kumhlophe
Ukuhlonza 1H-NMR	Ihambisana nesakhiwo esihlongozwayo
Ukuhlonza HPLC	Isikhathi sokugcina sesiqongo esiyinhloko ekulungiseleleni isampula kufanele sihambisane nesikhathi sokugcina senani eliphakeme ekulungiselelweni okujwayelekile kwereferensi.
I-Identification Mass	I-Mass Spectrum ihambisana nesakhiwo esihlongozwayo
I-Melting Point	188.0℃-193.0℃
Izinto Ezihlobene (Indawo evamile)	Noma Ikuphi Ukungcola Okukodwa: ≤0.10% (HPLC)
Izinto Ezihlobene (Indawo evamile)	Ukungcola Okuphelele: ≤1.0% (HPLC)
Ukuhlanzeka / Indlela Yokuhlaziya	≥99.0% (HPLC)
Umswakama (KF)	≤0.50%
Izinsalela ekushiseni	≤0.10%
Izinsimbi Ezisindayo	≤20ppm
Izincibilikisi Zensalela
I-Methanol	≤3000ppm
Isopropanol	≤5000ppm
n-Heptane	≤5000ppm
I-Ethanol	≤5000ppm
Izinga Lokuhlola	I-Enterprise Standard
Ukusetshenziswa	I-Active Pharmaceutical Ingredient (API);Ukwelashwa kwe-COVID-19

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard drum, noma ngokwezidingo zekhasimende.

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni, umswakama kanye nezinambuzane.

Izinzuzo:

I-FAQ:

Isicelo:

I-Favipiravir (T-705) (CAS 259793-96-9) ingenye yezinhlanganisela ezi-5 ezinconywe yi-WHO ukuze kuphenywe ukwelashwa kwe-COVID-19.I-Favipiravir iyi-inhibitor ekhethiwe ye-RNA polymerase encike ku-RNA esebenza ngokumelene namagciwane amaningi e-RNA, amagciwane omkhuhlane, igciwane le-West Nile, igciwane le-yellow fever, igciwane lesifo sonyawo nomlomo kanye namanye ama-flaviviruses, ama-arenavirus, ama-bunyaviruses nama-alphaviruses.I-Favipiravir isidakamizwa esilwa namagciwane esine-spectrum esibanzi esisulwe yi-Drugs Controller General of India (DCGI) ngesonto eledlule ukuze kusetshenziswe “imikhawulo ephuthumayo” phakathi kweziguli ze-Covid-19.I-Favipiravir yasungulwa ngasekupheleni kweminyaka yawo-1990 yinkampani eyathengwa kamuva inkampani yaseJapan i-Fujifilm njengengxenye yoshintsho isuka ebhizinisini lezithombe iye ekunakekelweni kwezempilo.Ngemva kokuhlolwa ngokumelene nohlu lwamagciwane, umuthi wagunyazwa e-Japan ngo-2014 ukuze usetshenziswe ezimeni eziphuthumayo ngokumelene nezifo eziwumshayabhuqe noma ukwelapha izinhlobo ezintsha zomkhuhlane.